About Provepharm Life Solutions
Provepharm Life Solutions is a company based in Marseille (France) founded in 1998. Provepharm Life Solutions has raised $145.93 million across 4 funding rounds from investors including Société Générale, BNP Paribas and Crédit Agricole. Provepharm Life Solutions has completed 1 acquisition, including Apollo Pharmaceuticals. Provepharm Life Solutions offers products and services including Specialty Pharmaceuticals and Medical Devices. Provepharm Life Solutions operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Symbiotec, Jubilant Pharma and SeQuent, among others.
- Headquarter Marseille, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Provepharm Life Solutions
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$145.93 M (USD)
in 4 rounds
-
Latest Funding Round
$142.32 M (USD), Private Equity Round
Sep 08, 2021
-
Investors
Société Générale
& 10 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Provepharm Life Solutions
Provepharm Life Solutions offers a comprehensive portfolio of products and services, including Specialty Pharmaceuticals and Medical Devices.
Develops innovative drugs for unmet hospital needs.
Provides tools to enhance patient care in hospitals.
People of Provepharm Life Solutions
Unlock access to complete
Funding Insights of Provepharm Life Solutions
Provepharm Life Solutions has successfully raised a total of $145.93M across 4 strategic funding rounds. The most recent funding activity was a Private Equity Round of $142.32 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Provepharm Life Solutions
Provepharm Life Solutions has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Société Générale, BNP Paribas and Crédit Agricole.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Debt and equity investments are managed by the private fund.
|
Locked | Locked | Locked | |
|
Private equity firm focused on energy, financial services, agriculture, and hospitality services
|
Locked | Locked | Locked | |
|
Healthcare industries are funded and supported globally by ARCHIMED.
|
Locked | Locked | Locked |
Investor details for Provepharm Life Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Provepharm Life Solutions
Provepharm Life Solutions has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Apollo Pharmaceuticals.
Investment portfolio details for Provepharm Life Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of development, production, marketing and distribution of hospital and pharmacy products
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Provepharm Life Solutions
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Provepharm Life Solutions
Detailed financials for Provepharm Life Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Provepharm Life Solutions Comparisons
Peer comparison for Provepharm Life Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Provepharm Life Solutions
Provepharm Life Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Symbiotec, Jubilant Pharma and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of Provepharm Life Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Provepharm Life Solutions
Complete news archive for Provepharm Life Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Provepharm Life Solutions
Provepharm Life Solutions was founded in 1998 and raised its 1st funding round 13 years after it was founded.
Provepharm Life Solutions is headquartered in Marseille, France. It is registered at Marseille, Provence-alpes-cote D'azur, France.
Michel Feraud is the current CEO of Provepharm Life Solutions.
Provepharm Life Solutions is a funded company, having raised a total of $145.93M across 4 funding rounds to date.
Provepharm Life Solutions was founded in 1998 in Marseille, France, as a specialty pharmaceutical company. Operations center on the production of active pharmaceutical ingredients and finished dosage forms for clinical trials, alongside preclinical services. Specialty products, including methylene blue compound, methylthioninium chloride solution, and methylene blue solutions for injection, are manufactured. Leadership is provided by CEO Michel Feraud, with activities spanning API development and drug valorization.
Provepharm Life Solutions's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Provepharm Life Solutions offers Specialty Pharmaceuticals and Medical Devices.
Provepharm Life Solutions has made 1 acquisition, including Apollo Pharmaceuticals.
Provepharm Life Solutions has 11 investors. Key investors include Société Générale, BNP Paribas, Crédit Agricole, Crédit Agricole, and Banque Populaire.